為達最佳瀏覽效果,建議使用 Chrome、Firefox 或 Microsoft Edge 的瀏覽器。

請至Edge官網下載 請至FireFox官網下載 請至Google官網下載
晴時多雲

    限制級
    您即將進入之新聞內容 需滿18歲 方可瀏覽。
    根據「電腦網路內容分級處理辦法」修正條文第六條第三款規定,已於網站首頁或各該限制級網頁,依台灣網站分級推廣基金會規定作標示。 台灣網站分級推廣基金會(TICRF)網站:http://www.ticrf.org.tw

    《TAIPEI TIMES》 Scientists behind mRNA vaccines win Tang Prize

    Tang Prize Foundation’s biopharmaceutical science prize selection committee convenor Chang Wen-Chuang, standing, announces winners of this year’s Tang Prize in Biopharmaceutical Science at a ceremony in Taipei yesterday.
Photo: CNA

    Tang Prize Foundation’s biopharmaceutical science prize selection committee convenor Chang Wen-Chuang, standing, announces winners of this year’s Tang Prize in Biopharmaceutical Science at a ceremony in Taipei yesterday. Photo: CNA

    2022/06/20 03:00

    HONORED: The techniques developed by Katalin Kariko, Drew Weissman and Pieter Cullis represent a paradigm shift in protein therapy, the Tang Prize Foundation said

    / Staff writer, with CNA

    Three scientists whose research laid the foundation for messenger RNA (mRNA) COVID-19 vaccines were named the winners of the 2022 Tang Prize in Biopharmaceutical Science at a ceremony in Taipei yesterday.

    Katalin Kariko, Drew Weissman and Pieter Cullis were recognized “for the discovery of key vaccinology concepts and approaches, leading to the successful development of mRNA-based COVID-19 vaccines,” the Tang Prize Foundation said.

    The technologies developed by the three laureates “not only revolutionized vaccinology, but also signaled a paradigm shift in protein therapy. They represent the advent of a new era of RNA-based therapies,” the foundation said.

    Kariko and Weissman, who have worked together for more than two decades, created a modified version of mRNA that would not cause an inflammatory response when injected into the body. The technology is used in the Pfizer-BioNTech and Moderna COVID-19 vaccines.

    Cullis is a pioneer in delivery systems for mRNA to human cells, based on lipid nanoparticles, which are bubbles of fat that wrap around and protect mRNA.

    In a recorded video, Kariko said she was honored and humbled to learn that she had received the award along with Weissman and Cullis.

    Weissman said a shared interest in science, a hunger for learning and perseverance formed the foundation of his partnership with Kariko.

    Cullis credited his collaborators and colleagues for the award.

    “The award is really being given for the work of literally hundreds of people that I’ve had the pleasure to work with over the last 40 years, so it’s really fantastic,” he said.

    The three also credited curiosity, collaboration and finding joy in their work as critical to their efforts in the research.

    Kariko is an adjunct professor at the University of Pennsylvania and a senior vice president at BioNTech. She was born in Hungary and moved to the US after obtaining a doctorate in biochemistry.

    Weissman, a US researcher, is the director of vaccine research at the University of Pennsylvania Perelman School of Medicine.

    Cullis is a professor of biochemistry and molecular biology at the University of British Columbia. The Canadian researcher has cofounded several companies, including Integrated Nano Therapeutics, Molecular You and Acuitus Therapeutics.

    The Tang Prize is a biennial award established in 2012 by Taiwanese entrepreneur Samuel Yin (尹衍樑), chairman of the Ruentex Group, to honor people who have made prominent contributions in four categories: sustainable development, biopharmaceutical science, Sinology and rule of law.

    The winners in each category share a cash award of NT$40 million (US$1.35 million) and NT$10 million in research funding.

    新聞來源:TAIPEI TIMES

    不用抽 不用搶 現在用APP看新聞 保證天天中獎  點我下載APP  按我看活動辦法

    焦點今日熱門

    網友回應

    此網頁已閒置超過5分鐘,請點擊透明黑底或右下角 X 鈕。